(-)-Citronellal

(-)-Citronellal

SCHEMBL726161

CC(C)=CCC[C@H](C)CC=O

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 3/20 0.57
ALDH1A1 P00352 3/20 0.57
TSHR P16473 1/20 0.52
USP2 O75604 1/20 0.42
TDP1 Q9NUW8 1/20 0.39
GGPS1 O95749 2/20 0.39
FDPS P14324 2/20 0.39
GLA P06280 1/20 0.38
HPGD P15428 1/20 0.38
NFE2L2 Q16236 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Citronellal SCHEMBL1864131 1.00 ALOX15 (0.57) ALOX15ALDH1A1TSHRUSP2TDP1
Citronellal SCHEMBL29275 1.00 ALOX15 (0.57) ALOX15ALDH1A1TSHRUSP2TDP1
Citronellal SCHEMBL457495 1.00 ALOX15 (0.57) ALOX15ALDH1A1TSHRUSP2TDP1
Citronellal SCHEMBL25260936 0.98 ALOX15 (0.55) ALOX15ALDH1A1TSHRUSP2TDP1
Citronellal SCHEMBL10553397 0.98 ALOX15 (0.55) ALOX15ALDH1A1TSHRUSP2TDP1
Citronellal SCHEMBL3310337 0.98 ALOX15 (0.55) ALOX15ALDH1A1TSHRUSP2TDP1
Citronellal SCHEMBL28427452 0.98 ALOX15 (0.55) ALOX15ALDH1A1TSHRUSP2TDP1
Citronellal SCHEMBL1179118 0.96 ALOX15 (0.53) ALOX15ALDH1A1TSHRUSP2TDP1
Citronellal SCHEMBL5361338 0.96 ALOX15 (0.53) ALOX15ALDH1A1TSHRUSP2TDP1
Citronellal SCHEMBL442629 0.94 ALOX15 (0.52) ALOX15ALDH1A1TSHRUSP2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 298 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260007137-A1 FRESHNESS ENHANCING LABELS, SHEETS, AND SACHETS RYP LABS, INC. (US) 2026-01-08 US claimed
EP-4598834-A1 SYSTEMS AND METHODS FOR CARRIER SYSTEMS FOR CONTROLLED RELEASE DELIVERY IN PERISHABLE GOODS RYP LABS, Inc. (US) 2025-08-13 EP claimed
EP-4587337-A1 FRESHNESS ENHANCING LABELS, SHEETS, AND SACHETS RYP LABS, Inc. (US) 2025-07-23 EP claimed
CN-119923356-A Systems and methods for controlled release delivery of carrier systems in perishable objects RYP实验室有限公司 2025-05-02 CN claimed
US-20240164395-A1 EDIBLE SPRAY OR COATING COMPOSITION FOR EXTENDING LIFE OF PERISHABLE GOODS AND METHODS OF PRODUCTION AND USE THEREOF RYP LABS, INC. (US) 2024-05-23 US claimed
WO-2024076874-A1 SYSTEMS AND METHODS FOR CARRIER SYSTEMS FOR CONTROLLED RELEASE DELIVERY IN PERISHABLE GOODS RYP LABS, INC. (US) 2024-04-11 WO claimed
WO-2024059786-A1 FRESHNESS ENHANCING LABELS, SHEETS, AND SACHETS RYP LABS, INC. (US) 2024-03-21 WO claimed
EP-4322758-A1 EDIBLE SPRAY OR COATING COMPOSITION FOR EXTENDING LIFE OF PERISHABLE GOODS AND METHODS OF PRODUCTION AND USE THEREOF RYP LABS, Inc. (US) 2024-02-21 EP claimed
CN-116396193-A Method for preparing alpha-sulfonamido acetals from fatty aldehydes and sulfonamides 西北工业大学 2023-07-07 CN claimed
WO-2022221443-A1 EDIBLE SPRAY OR COATING COMPOSITION FOR EXTENDING LIFE OF PERISHABLE GOODS AND METHODS OF PRODUCTION AND USE THEREOF RYP LABS, INC. (US) 2022-10-20 WO claimed
WO-2022217147-A1 METHODS FOR IMPROVING CUTANEOUS PERMEATION OF CANNABINOIDS AND FATTY ACID AMIDES ROSENFELD MARK J (US) 2022-10-13 WO claimed
CN-121653024-A Method for preparing (R) -citronellal through separation and coproducing (S) -citronellol 万华化学集团营养科技有限公司 2026-03-13 CN disclosed
US-20260007137-A1 FRESHNESS ENHANCING LABELS, SHEETS, AND SACHETS RYP LABS, INC. (US) 2026-01-08 US disclosed
US-12507703-B2 Methods, devices and compositions for preserving human milk THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2025-12-30 US disclosed
EP-4473051-B1 COMPOUND, RUBBER BLEND CONTAINING THE COMPOUND, VEHICLE TIRE COMPRISING THE RUBBER BLEND IN AT LEAST ONE COMPONENT, PROCESS FOR PREPARING THE COMPOUND, AND USE OF THE COMPOUND AS AN ANTI-AGING AGENT AND/OR ANTIOXIDANT CONTINENTAL REIFEN DEUTSCHLAND GMBH (DE) 2025-11-12 EP disclosed
US-7164034-B2 Alpha2delta ligands for fibromyalgia and other disorders PFIZER INC. (US) 2007-01-16 US disclosed
WO-2004054566-A1 PREGABALIN DERIVATIVES FOR THE TREATMENT OF FIBROMYALGIA AND OTHER DISORDERS WARNER-LAMBERT COMPANY LLC (US) 2004-07-01 WO disclosed
US-6121234-A ORALLY COADMINISTERING TO MAMMAL PHARMACEUTICAL COMPOUND AND ESSENTIAL OIL AVMAX, INC. (US) 2000-09-19 US disclosed
US-5916566-A Use of benzoin gum to inhibit P-glycoprotein-mediated resistance of pharmaceutical compounds AVMAX, INC. (US) 1999-06-29 US disclosed
US-5665386-A Use of essential oils to increase bioavailability of oral pharmaceutical compounds AVMAX, INC. (US) 1997-09-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12507703-B2 Methods, devices and compositions for preserving human milk LPL, CEL, LPO ALOX15 1489/4885ALDH1A1 1545/4885TSHR 3929/4885
US-20260007137-A1 FRESHNESS ENHANCING LABELS, SHEETS, AND SACHETS MYB, CASP1, PLIN1 ALOX15 745/4885ALDH1A1 564/4885TSHR 4653/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.